Dyslipidemia and SARS-CoV-2 spike antibody titres after the second and third doses of the BNT162b2 vaccine among healthcare workers in Japan.

Zobida IslamShohei YamamotoTetsuya MizoueYusuke OshiroNatsumi InamuraMaki KonishiMitsuru OzekiWataru SugiuraNorio Ohmagari

Published in: Diabetes/metabolism research and reviews (2022)

These results suggest a detrimental role of hypertriglyceridemia in the humoral immune response to the BNT162b2 vaccine for COVID-19 in men but not in women.

Keyphrases

sars cov
respiratory syndrome coronavirus
immune response
coronavirus disease
polycystic ovary syndrome
type diabetes
adipose tissue
insulin resistance
cervical cancer screening